American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

NovoCure Limited Ordinary Shares

NVCR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

NVCR historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of NVCR by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Marie Newman House / D Purchase $15,001 - $50,000 Jul 02, 2021
Donna E. Shalala House / D Sale $1,001 - $15,000 Jun 24, 2019
Donna E. Shalala House / D Purchase $1,001 - $15,000 Jun 19, 2019
NVCR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NVCR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NVCR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in NVCR holdings by institutional investors

Insider Trading

Quarterly net insider trading by NVCR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $160,000 Jul 19, 2026 Issue: Tariff (miscellaneous tariff bills) Medicare/Medicaid
  • $180,000 Apr 20, 2026 Issue: Medicare/Medicaid Tariff (miscellaneous tariff bills)
  • $110,000 Jan 17, 2026 Issue: Medicare/Medicaid Tariff (miscellaneous tariff bills)
  • $110,000 Oct 13, 2025 Issue: Medicare/Medicaid
  • $110,000 Jul 15, 2025 Issue: Medicare/Medicaid Veterans
  • $110,000 Apr 16, 2025 Issue: Medicare/Medicaid Veterans
  • $110,000 Jan 14, 2025 Issue: Medicare/Medicaid Veterans
  • $120,000 Oct 15, 2024 Issue: Veterans Medicare/Medicaid
  • $220,000 Jul 22, 2024 Issue: Veterans Medicare/Medicaid
  • $140,000 Oct 19, 2023 Issue: Medicare/Medicaid
  • $180,000 Aug 02, 2023 Issue: Transportation Veterans Medicare/Medicaid
  • $120,000 Feb 18, 2023 Issue: Transportation Veterans Medicare/Medicaid
  • $120,000 Oct 16, 2022 Issue: Veterans Medicare/Medicaid
  • $120,000 Jul 20, 2022 Issue: Veterans Medicare/Medicaid
  • $110,000 Apr 20, 2022 Issue: Medicare/Medicaid
  • $80,000 Jan 19, 2022 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $150,000 Oct 20, 2021 Issue: Health Issues
  • $20,000 Oct 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $100,000 Jul 20, 2021 Issue: Health Issues
  • $90,000 Apr 20, 2021 Issue: Health Issues
  • $100,000 Jan 18, 2021 Issue: Health Issues
  • $100,000 Oct 18, 2020 Issue: Science/Technology Medical/Disease Research/Clinical Labs Insurance Copyright/Patent/Trademark Health Issues Manufacturing Veterans Medicare/Medicaid Budget/Appropriations
  • $110,000 Jul 20, 2020 Issue: Science/Technology Health Issues Copyright/Patent/Trademark Manufacturing Veterans Medicare/Medicaid Budget/Appropriations Insurance Medical/Disease Research/Clinical Labs
  • $110,000 Apr 20, 2020 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Veterans Health Issues Copyright/Patent/Trademark Insurance Manufacturing Medicare/Medicaid Science/Technology
  • $180,000 Jan 20, 2020 Issue: Science/Technology Insurance Budget/Appropriations Veterans Health Issues Copyright/Patent/Trademark Manufacturing Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $140,000 Oct 21, 2019 Issue: Insurance Medicare/Medicaid Veterans Copyright/Patent/Trademark Manufacturing Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs Science/Technology
  • $120,000 Jul 22, 2019 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Manufacturing Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Insurance Science/Technology
  • $90,000 Apr 22, 2019 Issue: Health Issues
  • $90,000 Jan 22, 2019 Issue: Health Issues
  • $80,000 Oct 22, 2018 Issue: Health Issues
  • $80,000 Jul 19, 2018 Issue: Health Issues
  • $80,000 Apr 20, 2018 Issue: Health Issues
  • $28,000 Jan 22, 2018 Issue: Health Issues
  • $60,000 Jan 19, 2018 Issue: Health Issues
  • $84,000 Oct 20, 2017 Issue: Health Issues
  • $80,000 Jul 13, 2017 Issue: Health Issues
  • $80,000 Apr 19, 2017 Issue: Health Issues
  • $110,000 Jan 23, 2017 Issue: Health Issues
  • $50,000 Oct 20, 2016 Issue: Health Issues
  • $111,000 Jul 20, 2016 Issue: Health Issues
  • $50,000 Apr 20, 2016 Issue: Health Issues
  • $110,000 Jan 18, 2016 Issue: Health Issues
  • $50,000 Oct 20, 2015 Issue: Health Issues
  • $100,000 Jul 20, 2015 Issue: Health Issues
  • $60,000 Apr 20, 2015 Issue: Government Issues Medicare/Medicaid Health Issues
  • $40,000 Apr 15, 2015 Issue: Health Issues
  • $60,000 Jan 20, 2015 Issue: Health Issues
  • $10,000 Jan 20, 2015 Issue: Government Issues Medicare/Medicaid Health Issues
  • $60,000 Oct 20, 2014 Issue: Health Issues
  • $140,000 Oct 17, 2014 Issue: Government Issues Medicare/Medicaid Health Issues
  • $10,000 Jul 21, 2014 Issue: Health Issues
  • $130,000 Jul 21, 2014 Issue: Government Issues Health Issues Medicare/Medicaid
  • $30,000 Jul 21, 2014 Issue: Government Issues Medicare/Medicaid Health Issues
  • $30,000 Jul 21, 2014 Issue: Medicare/Medicaid Government Issues Health Issues
Revolving Door

Former government officials who have lobbied for NVCR

24 former government officials from 13 congressional offices at 5 lobbying firms have lobbied for NVCR, most recently Jul 20, 2026.

  • Chuck Grassley
    Jeanne Haggerty Senate Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member Formerly with Chuck Grassley · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
  • Bill Cassidy
    Robert Butora Senate Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess Formerly with Bill Cassidy · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
  • Doug Lamborn
    Daniel Ziegler House Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson Formerly with Doug Lamborn · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
  • Gary C. Peters
    Joshua Fendrick Senate Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters Formerly with Gary C. Peters · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
  • Jennifer Young Congress Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 20, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 20, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 20, 2026
  • Tom Harkin
    Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc. of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun Formerly with Tom Harkin · TARPLIN, DOWNS & YOUNG, LLC · Jul 20, 2026
See all 24 on the Revolving Door dashboard
Corporate Lobbying

NVCR Estimated quarterly lobbying spending

Revenue Breakdown

NVCR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NVCR Income Statement
NVCR Balance Sheet
NVCR Cash Flow
U.S. Patents

New NVCR patent grants

  • Patent Title: Container with cover Sep. 08, 2026
  • Patent Title: Animal cage Aug. 25, 2026
  • Patent Title: Carrying case Aug. 11, 2026
  • Patent Title: Animal cage Aug. 04, 2026
  • Patent Title: Medical treatment apparatus Jul. 21, 2026
  • Patent Title: Medical treatment apparatus May. 05, 2026
  • Patent Title: Electrode array Mar. 03, 2026
  • Patent Title: Electrode array Feb. 24, 2026
  • Patent Title: Electrode array Feb. 17, 2026
  • Patent Title: Electrode array Feb. 17, 2026
  • Patent Title: Medical treatment device Nov. 04, 2025
  • Patent Title: Electrode array Jun. 03, 2025
  • Patent Title: Electrode array Jun. 03, 2025
  • Patent Title: Electrode array May. 27, 2025
  • Patent Title: Electrode array May. 27, 2025
  • Patent Title: Electrode array May. 27, 2025
  • Patent Title: Animal cage Jan. 14, 2025
  • Patent Title: Electrode array Dec. 31, 2024
  • Patent Title: Electrode array Dec. 31, 2024
  • Patent Title: Electrode array Dec. 24, 2024
  • Patent Title: Carrying case Sep. 17, 2024
  • Patent Title: Medical treatment device Aug. 20, 2024
  • Patent Title: Electrode array Jan. 02, 2024
  • Patent Title: Electrode array Jan. 02, 2024
  • Patent Title: Electrode array Jan. 02, 2024
  • Patent Title: Electrode array Jan. 02, 2024
  • Patent Title: Electrode array Dec. 26, 2023
  • Patent Title: Electrode array Aug. 09, 2022
  • Patent Title: Electrode array Aug. 02, 2022
  • Patent Title: Display screen or portion thereof with a graphical user interface Nov. 02, 2021
  • Patent Title: High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude Mar. 06, 2018
  • Patent Title: Treating bacteria with electric fields Sep. 05, 2017
  • Patent Title: Optimizing treatment using ttfields by changing the frequency during the course of long term tumor treatment May. 23, 2017
  • Patent Title: Treating bacteria with electric fields Sep. 13, 2016
  • Patent Title: Treating bacteria with electric fields Jun. 16, 2015
  • Patent Title: Treating bacteria with electric fields May. 26, 2015
  • Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy May. 05, 2015
  • Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy May. 05, 2015
  • Patent Title: Composite electrode Jul. 01, 2014
  • Patent Title: Optimizing characteristics of an electric field to increase the field's effect on proliferating cells May. 06, 2014
  • Patent Title: Composite electrode May. 06, 2014
  • Patent Title: Treating a tumor or the like with electric fields at different frequencies Apr. 22, 2014
  • Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy Jun. 18, 2013
  • Patent Title: Treating bacteria with electric fields May. 21, 2013
  • Patent Title: Treating bacteria with electric fields May. 21, 2013
  • Patent Title: Treating cancer using electromagnetic fields in combination with other treatment regimens Mar. 26, 2013
  • Patent Title: Method and apparatus for destroying dividing cells Aug. 28, 2012
  • Patent Title: Treating a tumor or the like with electric fields at different frequencies Aug. 14, 2012
  • Patent Title: Probe for treating a tumor or the like Jul. 24, 2012
  • Patent Title: Treating bacteria with electric fields May. 08, 2012
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to NVCR from public contracts

NVCR News

Recent insights relating to NVCR

CNBC Recommendations

Recent picks made for NVCR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVCR

NVCR Analyst Ratings

NVCR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NVCR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NVCR stock a Buy, Sell, or Hold?

  • What is the price target for $NVCR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NVCR Top Shareholders
Shareholder
Shares Held
NVCR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NVCR stock?

  • Who owns the most shares of $NVCR stock?

  • What funds own $NVCR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NVCR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NVCR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NVCR

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

NovoCure Limited Ordinary Shares (NVCR) Historical Stock Prices

NovoCure Limited Ordinary Shares (NVCR) closed at $16.20 on September 24, 2026. Over the past year its adjusted close ranged from $10.03 to $19.99. Daily prices go back to October 2, 2015, 2,760 trading days in all.

  • 1 month-8.06%
  • 3 months+7.64%
  • Year to date+25.29%
  • 1 year+26.17%
  • 3 years-6.57%
  • 5 years-87.27%
  • Max-11.38%
See every congressional and insider trade on the NVCR price chart

Quiver Premium charts NVCR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 16.43 16.43 15.73 16.20 16.20 1,142,632
Sep 23, 2026 16.53 16.75 15.97 16.25 16.25 777,756
Sep 22, 2026 16.70 16.79 16.54 16.67 16.67 1,044,654
Sep 21, 2026 16.87 16.87 16.37 16.53 16.53 633,460
Sep 18, 2026 16.70 16.87 16.52 16.69 16.69 1,152,697
Sep 17, 2026 16.58 16.99 16.13 16.72 16.72 1,483,006
Sep 16, 2026 16.18 16.55 16.00 16.22 16.22 1,639,362
Sep 15, 2026 16.13 16.66 15.96 16.15 16.15 914,851
Sep 14, 2026 15.49 16.25 15.29 16.22 16.22 1,049,273
Sep 11, 2026 15.50 16.00 15.35 15.51 15.51 1,127,182
Sep 10, 2026 15.26 16.07 15.10 15.35 15.35 1,385,210
Sep 9, 2026 16.56 16.64 15.60 15.63 15.63 996,520
Sep 8, 2026 17.64 17.77 16.57 16.85 16.85 1,460,201
Sep 4, 2026 17.53 18.02 17.47 17.94 17.94 732,170
Sep 3, 2026 17.94 18.05 17.42 17.64 17.64 613,412
Sep 2, 2026 17.88 18.59 17.50 17.83 17.83 1,324,037
Sep 1, 2026 17.36 17.88 17.29 17.38 17.38 800,360
Aug 31, 2026 17.55 17.97 17.39 17.65 17.65 914,820
Aug 28, 2026 17.99 18.16 17.42 17.82 17.82 855,579
Aug 27, 2026 17.92 18.21 17.48 17.99 17.99 763,436
Aug 26, 2026 17.43 17.97 17.15 17.89 17.89 1,270,871
Aug 25, 2026 16.98 17.64 16.92 17.62 17.62 902,955
Aug 24, 2026 17.02 17.05 16.33 16.76 16.76 1,607,226
Aug 21, 2026 17.75 17.82 17.01 17.10 17.10 1,404,005
Aug 20, 2026 18.12 18.61 17.48 17.77 17.77 955,714
Aug 19, 2026 17.40 18.34 17.38 18.20 18.20 4,838,625
Aug 18, 2026 17.25 17.73 17.08 17.24 17.24 792,636
Aug 17, 2026 16.78 17.76 16.78 17.53 17.53 1,448,856
Aug 14, 2026 17.23 17.23 16.80 16.95 16.95 681,335
Aug 13, 2026 17.53 17.75 17.18 17.38 17.38 637,127
Aug 12, 2026 17.66 17.68 17.22 17.59 17.59 764,680
Aug 11, 2026 17.34 17.83 17.29 17.66 17.66 923,859
Aug 10, 2026 16.27 17.59 16.27 17.31 17.31 1,045,128
Aug 7, 2026 15.60 16.42 15.60 16.39 16.39 1,529,221
Aug 6, 2026 16.20 16.20 15.58 15.69 15.69 943,318
Aug 5, 2026 16.14 16.25 15.93 16.05 16.05 1,234,122
Aug 4, 2026 15.28 16.30 15.23 16.27 16.27 1,740,210
Aug 3, 2026 15.00 15.69 15.00 15.32 15.32 1,642,986
Jul 31, 2026 15.46 15.72 14.83 14.84 14.84 1,228,737
Jul 30, 2026 15.20 15.49 15.04 15.23 15.23 1,414,848
Jul 29, 2026 16.06 16.39 15.12 15.20 15.20 1,506,697
Jul 28, 2026 16.99 17.05 16.16 16.31 16.31 1,383,902
Jul 27, 2026 17.97 18.15 16.86 17.03 17.03 1,811,940
Jul 24, 2026 20.68 21.45 17.60 17.65 17.65 3,880,148
Jul 23, 2026 18.00 20.55 18.00 19.99 19.99 8,948,689
Jul 22, 2026 15.99 16.12 15.20 15.57 15.57 1,064,781
Jul 21, 2026 15.91 16.41 15.84 16.00 16.00 1,069,311
Jul 20, 2026 16.00 16.19 15.79 15.94 15.94 933,512
Jul 17, 2026 16.08 16.52 15.83 15.92 15.92 856,319
Jul 16, 2026 16.05 16.52 16.03 16.42 16.42 1,117,924
Jul 15, 2026 15.52 16.06 15.31 16.03 16.03 1,100,966
Jul 14, 2026 16.30 16.30 15.31 15.55 15.55 1,156,812
Jul 13, 2026 15.91 16.43 15.79 16.09 16.09 857,463
Jul 10, 2026 17.20 17.35 16.01 16.30 16.30 1,948,450
Jul 9, 2026 17.63 18.01 17.18 17.29 17.29 1,049,957
Jul 8, 2026 17.28 18.08 17.16 17.37 17.37 3,335,527
Jul 7, 2026 17.13 17.76 16.64 17.72 17.72 1,057,795
Jul 6, 2026 17.00 17.80 16.80 17.32 17.32 1,711,142
Jul 2, 2026 15.87 17.31 15.61 17.20 17.20 1,953,473
Jul 1, 2026 15.38 16.00 15.29 15.78 15.78 1,351,505
Jun 30, 2026 15.47 15.60 14.96 15.15 15.15 1,412,328
Jun 29, 2026 15.42 15.60 15.14 15.48 15.48 1,106,480
Jun 26, 2026 14.91 15.63 14.90 15.43 15.43 3,294,090
Jun 25, 2026 14.71 15.19 14.63 15.05 15.05 1,290,324
Jun 24, 2026 14.17 15.11 14.17 14.72 14.72 1,549,305
Jun 23, 2026 13.43 14.31 13.43 14.13 14.13 1,752,294
Jun 22, 2026 14.33 14.51 13.51 13.61 13.61 1,956,680
Jun 18, 2026 15.03 15.10 13.88 14.28 14.28 4,850,209
Jun 17, 2026 17.53 18.00 17.36 17.85 17.85 1,308,959
Jun 16, 2026 17.60 17.90 17.44 17.49 17.49 1,022,530
Jun 15, 2026 18.32 18.35 17.48 17.60 17.60 2,767,816
Jun 12, 2026 17.62 18.05 17.25 17.78 17.78 1,037,315
Jun 11, 2026 16.74 17.73 16.41 17.71 17.71 1,348,095
Jun 10, 2026 17.03 17.54 16.62 16.65 16.65 982,195
Jun 9, 2026 17.07 17.66 16.98 17.24 17.24 1,544,076
Jun 8, 2026 17.26 17.91 16.83 16.85 16.85 1,178,802
Jun 5, 2026 17.60 17.97 17.00 17.16 17.16 2,168,013
Jun 4, 2026 16.23 18.39 16.23 17.99 17.99 2,251,244
Jun 3, 2026 15.64 16.17 14.85 16.15 16.15 1,696,158
Jun 2, 2026 16.48 16.48 15.65 15.82 15.82 1,390,346
Jun 1, 2026 17.02 17.79 16.49 16.56 16.56 1,603,691
May 29, 2026 17.22 17.64 16.86 17.04 17.04 1,339,347
May 28, 2026 16.94 17.55 16.67 17.25 17.25 1,211,067
May 27, 2026 18.26 18.34 16.78 16.99 16.99 1,481,663
May 26, 2026 18.00 18.67 17.80 18.26 18.26 1,929,520
May 22, 2026 17.98 18.17 17.78 17.96 17.96 848,886
May 21, 2026 17.50 18.17 17.33 17.90 17.90 1,129,683
May 20, 2026 17.10 17.87 16.86 17.75 17.75 1,319,063
May 19, 2026 17.32 17.53 16.99 17.01 17.01 994,767
May 18, 2026 17.76 18.40 17.35 17.46 17.46 1,822,159
May 15, 2026 17.82 18.25 17.44 17.58 17.58 1,408,670
May 14, 2026 18.13 18.43 17.82 18.05 18.05 1,560,866
May 13, 2026 18.12 18.50 17.84 18.10 18.10 1,153,693
May 12, 2026 18.11 18.51 17.70 18.31 18.31 1,488,320
May 11, 2026 17.87 18.92 17.85 18.10 18.10 2,593,329
May 8, 2026 16.90 18.19 16.85 17.89 17.89 2,377,008
May 7, 2026 16.61 17.21 16.12 16.83 16.83 1,475,874
May 6, 2026 15.91 16.74 15.40 16.50 16.50 1,511,219
May 5, 2026 16.75 16.76 15.79 15.88 15.88 1,957,137
May 4, 2026 16.43 17.22 16.34 16.93 16.93 3,093,713
May 1, 2026 15.48 16.70 15.35 16.62 16.62 3,647,392
Apr 30, 2026 13.36 15.52 13.30 15.21 15.21 7,710,540
Apr 29, 2026 12.00 12.00 11.61 11.93 11.93 1,130,389
Apr 28, 2026 12.44 12.65 12.08 12.12 12.12 1,481,758
Apr 27, 2026 12.41 12.70 12.32 12.48 12.48 868,780
Apr 24, 2026 12.69 12.83 12.31 12.47 12.47 781,870
Apr 23, 2026 12.96 13.12 12.24 12.59 12.59 953,742
Apr 22, 2026 12.46 13.16 12.43 13.02 13.02 1,371,875
Apr 21, 2026 12.66 12.75 12.14 12.23 12.23 885,056
Apr 20, 2026 12.72 13.07 12.50 12.67 12.67 832,466
Apr 17, 2026 12.99 13.17 12.78 12.83 12.83 1,401,992
Apr 16, 2026 12.24 12.73 12.13 12.62 12.62 1,603,196
Apr 15, 2026 11.30 12.44 11.30 12.17 12.17 2,017,044
Apr 14, 2026 10.90 11.38 10.85 11.30 11.30 992,061
Apr 13, 2026 10.41 10.77 10.40 10.72 10.72 770,451
Apr 10, 2026 11.00 11.00 10.53 10.58 10.58 809,736
Apr 9, 2026 10.68 11.00 10.56 11.00 11.00 977,581
Apr 8, 2026 11.05 11.32 10.64 10.79 10.79 1,194,774
Apr 7, 2026 10.42 10.48 10.13 10.35 10.35 941,916
Apr 6, 2026 10.51 10.69 10.44 10.55 10.55 830,021
Apr 2, 2026 10.52 10.87 10.30 10.55 10.55 1,154,360
Apr 1, 2026 11.03 11.30 10.84 10.84 10.84 954,812
Mar 31, 2026 10.42 10.94 10.25 10.90 10.90 1,217,442
Mar 30, 2026 10.92 11.01 10.32 10.36 10.36 1,335,477
Mar 27, 2026 11.62 11.62 10.94 10.97 10.97 1,213,684
Mar 26, 2026 11.80 12.30 11.41 11.76 11.76 1,331,446
Mar 25, 2026 11.65 11.83 11.47 11.61 11.61 1,145,030
Mar 24, 2026 11.59 11.71 11.24 11.36 11.36 1,097,153
Mar 23, 2026 11.94 12.19 11.63 11.82 11.82 1,545,384
Mar 20, 2026 12.14 12.14 11.46 11.81 11.81 1,653,056
Mar 19, 2026 12.21 12.37 11.93 12.15 12.15 854,693
Mar 18, 2026 11.97 12.30 11.79 12.06 12.06 1,174,497
Mar 17, 2026 12.49 12.84 12.30 12.35 12.35 2,096,087
Mar 16, 2026 12.24 12.58 12.16 12.38 12.38 771,887
Mar 13, 2026 12.06 12.33 11.87 12.06 12.06 653,145
Mar 12, 2026 12.31 12.46 11.79 12.01 12.01 1,023,141
Mar 11, 2026 12.57 12.74 12.23 12.62 12.62 972,881
Mar 10, 2026 12.99 13.16 12.47 12.75 12.75 877,685
Mar 9, 2026 12.60 13.12 12.45 12.91 12.91 1,345,370
Mar 6, 2026 13.64 13.91 13.01 13.04 13.04 1,449,790
Mar 5, 2026 13.02 14.33 13.02 14.23 14.23 2,315,546
Mar 4, 2026 13.18 13.51 12.79 13.42 13.42 1,761,930
Mar 3, 2026 12.88 13.55 12.25 13.30 13.30 1,950,066
Mar 2, 2026 13.54 13.71 13.28 13.52 13.52 1,912,053
Feb 27, 2026 13.55 14.38 13.26 13.67 13.67 2,582,752
Feb 26, 2026 13.25 13.94 11.80 13.75 13.75 5,490,830
Feb 25, 2026 12.55 15.46 12.50 14.99 14.99 8,259,435
Feb 24, 2026 10.98 11.87 10.93 11.74 11.74 2,339,042
Feb 23, 2026 11.28 11.38 10.80 10.98 10.98 1,440,274
Feb 20, 2026 11.31 11.47 11.11 11.36 11.36 1,280,971
Feb 19, 2026 11.28 11.47 11.04 11.39 11.39 1,223,983
Feb 18, 2026 11.05 11.45 10.95 11.40 11.40 1,772,015
Feb 17, 2026 11.14 11.36 10.69 11.13 11.13 2,424,163
Feb 13, 2026 12.54 12.99 10.93 10.99 10.99 3,608,746
Feb 12, 2026 14.40 14.97 12.01 12.53 12.53 16,691,120
Feb 11, 2026 10.48 10.53 10.15 10.50 10.50 2,815,665
Feb 10, 2026 10.10 10.64 10.09 10.47 10.47 1,615,048
Feb 9, 2026 10.12 10.20 9.82 10.03 10.03 1,214,984
Feb 6, 2026 10.34 10.37 9.93 10.14 10.14 1,850,284
Feb 5, 2026 11.55 11.65 9.82 10.09 10.09 5,330,539
Feb 4, 2026 11.92 12.21 11.48 11.56 11.56 1,643,758
Feb 3, 2026 12.19 12.91 11.78 11.84 11.84 1,174,111
Feb 2, 2026 12.28 12.56 12.16 12.19 12.19 1,328,807
Jan 30, 2026 12.37 12.57 12.24 12.40 12.40 1,320,219
Jan 29, 2026 12.63 12.78 12.34 12.38 12.38 823,184
Jan 28, 2026 13.05 13.11 12.55 12.58 12.58 1,489,319
Jan 27, 2026 13.12 13.24 12.91 13.05 13.05 975,911
Jan 26, 2026 13.36 13.43 13.13 13.26 13.26 707,157
Jan 23, 2026 14.08 14.10 13.35 13.45 13.45 903,716
Jan 22, 2026 13.70 14.29 13.67 14.19 14.19 1,039,473
Jan 21, 2026 13.07 13.64 13.05 13.56 13.56 1,564,445
Jan 20, 2026 13.12 13.32 12.80 13.02 13.02 870,134
Jan 16, 2026 13.75 14.07 13.50 13.64 13.64 792,014
Jan 15, 2026 13.79 13.88 13.50 13.80 13.80 1,412,729
Jan 14, 2026 13.38 13.96 13.34 13.77 13.77 922,916
Jan 13, 2026 13.86 13.98 13.28 13.65 13.65 1,325,032
Jan 12, 2026 15.01 15.03 13.40 14.18 14.18 1,664,490
Jan 9, 2026 14.97 15.15 14.33 14.35 14.35 1,008,700
Jan 8, 2026 14.27 14.95 14.13 14.87 14.87 1,352,683
Jan 7, 2026 14.26 14.62 14.26 14.41 14.41 1,074,115
Jan 6, 2026 13.68 14.34 13.68 14.29 14.29 1,550,905
Jan 5, 2026 13.15 13.94 13.14 13.77 13.77 1,436,046
Jan 2, 2026 13.18 13.51 12.96 13.12 13.12 1,714,304
Dec 31, 2025 13.12 13.19 12.88 12.93 12.93 1,126,355
Dec 30, 2025 13.20 13.40 13.18 13.22 13.22 546,757
Dec 29, 2025 13.43 13.64 13.20 13.27 13.27 775,199
Dec 26, 2025 13.43 13.57 13.25 13.48 13.48 658,857
Dec 24, 2025 13.27 13.53 13.23 13.44 13.44 401,503
Dec 23, 2025 13.35 13.38 12.98 13.27 13.27 962,477
Dec 22, 2025 12.84 13.97 12.80 13.44 13.44 1,442,853
Dec 19, 2025 12.60 12.87 12.60 12.84 12.84 1,835,970
Dec 18, 2025 12.48 12.78 12.38 12.56 12.56 1,113,287
Dec 17, 2025 12.88 13.12 12.30 12.33 12.33 1,857,260
Dec 16, 2025 12.94 13.19 12.83 12.93 12.93 1,088,354
Dec 15, 2025 13.42 13.49 12.96 12.97 12.97 3,699,079
Dec 12, 2025 13.58 13.69 13.25 13.32 13.32 2,087,065
Dec 11, 2025 13.25 13.94 13.23 13.66 13.66 1,980,813
Dec 10, 2025 12.70 13.25 12.62 13.22 13.22 1,355,574
Dec 9, 2025 12.05 12.83 12.00 12.70 12.70 2,251,295
Dec 8, 2025 12.24 12.32 11.82 12.06 12.06 1,403,958
Dec 5, 2025 11.85 12.21 11.74 12.11 12.11 2,254,906
Dec 4, 2025 11.77 11.83 11.36 11.76 11.76 1,787,474
Dec 3, 2025 10.93 11.86 10.93 11.81 11.81 2,330,116
Dec 2, 2025 11.82 11.84 10.79 10.92 10.92 2,885,028
Dec 1, 2025 12.11 12.57 11.48 11.68 11.68 3,122,631
Nov 28, 2025 12.79 12.89 12.61 12.81 12.81 736,145
Nov 26, 2025 12.81 12.82 12.53 12.76 12.76 1,235,957
Nov 25, 2025 12.59 12.68 12.45 12.64 12.64 1,467,317
Nov 24, 2025 11.95 12.56 11.92 12.53 12.53 1,758,265
Nov 21, 2025 11.40 12.17 11.38 11.95 11.95 1,992,514
Nov 20, 2025 11.54 12.13 11.44 11.46 11.46 1,633,042
Nov 19, 2025 11.43 11.57 11.14 11.45 11.45 1,351,137
Nov 18, 2025 11.23 11.63 11.09 11.45 11.45 1,580,726
Nov 17, 2025 11.30 11.44 11.12 11.27 11.27 1,562,848
Nov 14, 2025 11.28 11.66 11.20 11.32 11.32 1,498,104
Nov 13, 2025 11.24 11.74 11.24 11.38 11.38 1,593,885
Nov 12, 2025 11.91 11.96 11.33 11.36 11.36 1,353,434
Nov 11, 2025 11.27 12.01 11.15 11.86 11.86 1,282,769
Nov 10, 2025 10.96 11.27 10.89 11.27 11.27 5,108,155
Nov 7, 2025 11.02 11.12 10.70 10.92 10.92 2,235,017
Nov 6, 2025 11.48 11.50 11.24 11.27 11.27 1,221,888
Nov 5, 2025 12.05 12.05 11.30 11.61 11.61 1,436,214
Nov 4, 2025 12.04 12.21 11.86 12.00 12.00 1,615,998
Nov 3, 2025 12.80 12.80 12.19 12.23 12.23 1,661,833
Oct 31, 2025 12.79 13.01 12.47 12.81 12.81 1,844,620
Oct 30, 2025 13.48 14.22 12.73 12.82 12.82 2,221,830
Oct 29, 2025 13.29 13.71 13.29 13.48 13.48 1,311,509
Oct 28, 2025 13.60 13.77 13.20 13.37 13.37 1,058,916
Oct 27, 2025 13.75 13.94 13.54 13.58 13.58 1,123,454
Oct 24, 2025 14.17 14.17 13.53 13.75 13.75 1,061,533
Oct 23, 2025 13.83 14.05 13.64 13.92 13.92 702,863
Oct 22, 2025 14.25 14.44 13.81 13.86 13.86 935,348
Oct 21, 2025 14.50 14.57 14.07 14.13 14.13 1,055,977
Oct 20, 2025 14.06 14.58 14.03 14.48 14.48 1,519,399
Oct 17, 2025 13.77 14.13 13.55 13.78 13.78 1,015,028
Oct 16, 2025 14.34 14.62 13.93 14.03 14.03 1,148,916
Oct 15, 2025 13.30 14.19 13.28 14.18 14.18 1,452,305
Oct 14, 2025 12.96 13.37 12.84 13.17 13.17 1,463,072
Oct 13, 2025 13.61 13.72 13.12 13.24 13.24 1,327,943
Oct 10, 2025 14.35 14.45 13.24 13.49 13.49 1,177,489
Oct 9, 2025 14.33 14.69 14.08 14.33 14.33 1,316,713
Oct 8, 2025 14.20 14.58 14.12 14.35 14.35 1,071,857
Oct 7, 2025 14.50 14.62 13.94 14.16 14.16 1,272,458
Oct 6, 2025 14.73 14.77 14.16 14.50 14.50 1,732,368
Oct 3, 2025 14.17 14.69 14.15 14.66 14.66 1,198,282
Oct 2, 2025 13.96 14.12 13.68 14.05 14.05 1,544,680
Oct 1, 2025 12.82 14.16 12.82 13.98 13.98 9,050,763
Sep 30, 2025 12.99 13.04 12.61 12.92 12.92 1,361,617
Sep 29, 2025 12.91 13.01 12.72 12.92 12.92 1,117,166
Sep 26, 2025 12.91 13.00 12.74 12.89 12.89 1,180,095
Sep 25, 2025 12.70 12.84 12.46 12.78 12.78 1,488,585
Sep 24, 2025 13.00 13.10 12.69 12.84 12.84 1,410,474

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
NovoCure Limited Ordinary Shares Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NVCR, per a recent SEC DEF 14A filing. We estimate that the median employee at NovoCure Ltd is paid $141,515.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation